IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
+22.57%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$61.1M
Cap. Flow
-$36.5M
Cap. Flow %
-11.09%
Top 10 Hldgs %
43.78%
Holding
155
New
31
Increased
13
Reduced
30
Closed
17

Top Buys

1
CLDX icon
Celldex Therapeutics
CLDX
$21.4M
2
BPMC
Blueprint Medicines
BPMC
$15.7M
3
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$9.46M
4
GOSS icon
Gossamer Bio
GOSS
$9.15M
5
BDTX icon
Black Diamond Therapeutics
BDTX
$7.49M

Top Sells

1
BTAI icon
BioXcel Therapeutics
BTAI
$22.5M
2
XLRN
Acceleron Pharma Inc.
XLRN
$21.5M
3
ARGX icon
argenx
ARGX
$14.4M
4
IMVT icon
Immunovant
IMVT
$13.6M
5
MYOV
Myovant Sciences Ltd.
MYOV
$8.74M

Sector Composition

1 Healthcare 96.18%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CLVS
76
DELISTED
Clovis Oncology, Inc.
CLVS
$101K 0.01%
14,918
-397,000
-96% -$2.69M
CSCI
77
COSCIENS Biopharma Inc. Common Stock
CSCI
$8.64M
$94K 0.01%
1,174
– –
INSM icon
78
Insmed
INSM
$30.1B
$80K 0.01%
2,919
-170,000
-98% -$4.66M
DTIL icon
79
Precision BioSciences
DTIL
$59.3M
$73K 0.01%
+294
New +$73K
APLS icon
80
Apellis Pharmaceuticals
APLS
$3.62B
$69K 0.01%
2,126
-50,000
-96% -$1.62M
MITO
81
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$69K 0.01%
37,597
– –
DNTH icon
82
Dianthus Therapeutics
DNTH
$794M
$65K 0.01%
+542
New +$65K
XFOR icon
83
X4 Pharmaceuticals
XFOR
$81.7M
$47K ﹤0.01%
+167
New +$47K
ALPN
84
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$46K ﹤0.01%
+4,739
New +$46K
VIRX
85
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$29K ﹤0.01%
3,184
– –
VKTX icon
86
Viking Therapeutics
VKTX
$2.98B
$8K ﹤0.01%
1,159
-125,000
-99% -$863K
ABBV icon
87
AbbVie
ABBV
$376B
– –
0
– –
ALNY icon
88
Alnylam Pharmaceuticals
ALNY
$59.4B
– –
0
– –
AMRN
89
Amarin Corp
AMRN
$311M
– –
0
– –
ASND icon
90
Ascendis Pharma
ASND
$12B
– –
0
– –
AXSM icon
91
Axsome Therapeutics
AXSM
$6.21B
– –
0
– –
BBIO icon
92
BridgeBio Pharma
BBIO
$9.91B
– –
-87,900
Closed -$2.55M
BMRN icon
93
BioMarin Pharmaceuticals
BMRN
$10.9B
– –
0
– –
CHRS icon
94
Coherus Oncology, Inc. Common Stock
CHRS
$152M
– –
0
– –
CRBP icon
95
Corbus Pharmaceuticals
CRBP
$123M
– –
0
– –
CRSP icon
96
CRISPR Therapeutics
CRSP
$4.8B
– –
0
– –
CVM icon
97
CEL-SCI Corp
CVM
$77.4M
– –
0
– –
CYTK icon
98
Cytokinetics
CYTK
$5.95B
– –
0
– –
FATE icon
99
Fate Therapeutics
FATE
$112M
– –
0
– –
FGEN icon
100
FibroGen
FGEN
$45.7M
– –
0
– –
2 3
4
5 6